Back
Structure Therapeutics Vs. Cassava Sciences Industry Stock Comparison
Sell
16
GPCR
Structure Therapeutics
Last Price:
32.89
Seasonality Move:
-11.15%
Buy
63
SAVA
Cassava Sciences
Last Price:
26.95
Seasonality Move:
47.33%
Sell
16
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy, Sell or Hold?
- The current Structure Therapeutics [GPCR] share price is $30.10. The Score for GPCR is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- GPCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $32.18. The Score for SAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPCR Stock Price Chart
What is Structure Therapeutics's stock price today?
-
The Structure Therapeutics share price today is $30.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $32.18
The current trend is moderately bullish and SAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.9 | Sell |
Relative Strength Index (14 RSI): | 29.57 | Sell |
Chaikin Money Flow: | -746574 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.51 - 40.09) | Sell |
Bollinger Bands (100): | (35.63 - 41.33) | Sell |
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 64.8 | Buy |
Chaikin Money Flow: | 2523870 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.39 - 28.53) | Buy |
Bollinger Bands (100): | (17.94 - 31.2) | Buy |
GPCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.06 | Sell |
20-day SMA: | 36.96 | Sell |
50-day SMA: | 38.95 | Sell |
200-day SMA: | 39.82 | Sell |
8-day EMA: | 33.62 | Sell |
20-day EMA: | 36 | Sell |
50-day EMA: | 37.78 | Sell |
200-day EMA: | 39.23 | Sell |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.35 | Buy |
20-day SMA: | 26.62 | Buy |
50-day SMA: | 27.56 | Buy |
200-day SMA: | 22.93 | Buy |
8-day EMA: | 27.96 | Buy |
20-day EMA: | 27.22 | Buy |
50-day EMA: | 26.84 | Buy |
200-day EMA: | 24.22 | Buy |
Structure Therapeutics Earnings Growth & GPCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Structure Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cassava Sciences Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |